Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vectors derived from simian immunodeficiency virus (SIV).

Didier Nègre1, François-Loïc Cosset

  • 1Laboratoire de vectorologie rétrovirale et thérapie génique. INSERM U412, IFR 74, Ecole normale supérieure de Lyon, 46, allée d'Italie, France.

Biochimie
|February 22, 2003
PubMed
Summary

Lentiviral vectors can deliver genes into non-dividing cells, offering potential for in vivo gene therapy. This review examines simian immunodeficiency virus (SIV)-derived lentiviral vectors for their efficiency and safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Cytosolic Zinc Finger Domain Structure of the CCHFV Glycoprotein n Is Maintained in Its Membrane-Bound Form.

Journal of the American Chemical Society·2026
Same author

The Crimean-Congo haemorrhagic fever virus hijacks the liver lipid metabolic pathway for virion production.

Emerging microbes & infections·2026
Same author

TLR9 Downregulation in Breast Cancer: Its Role in Tumor Immunity, Inflammatory Response, and Cellular Senescence.

Journal of innate immunity·2025
Same author

A Large-Scale Serological Survey in Pets From October 2020 Through June 2021 in France Shows Significantly Higher Exposure to SARS-CoV-2 in Cats Compared to Dogs.

Zoonoses and public health·2024
Same author

Lipoprotein receptors: A little grease for enveloped viruses to open the lock?

The Journal of biological chemistry·2024
Same author

First Detection of Antibodies Specific to Crimean-Congo Hemorrhagic Fever Virus in Rural Populations of Gabon.

The American journal of tropical medicine and hygiene·2024

Area of Science:

  • Virology
  • Gene Therapy
  • Molecular Biology

Background:

  • Lentiviruses, unlike other retroviruses, can infect non-proliferating cells.
  • Lentiviral vectors are promising for in vivo gene delivery due to stable transgene integration in quiescent cells.
  • Vectors derived from pathogenic lentiviruses raise safety concerns, necessitating exploration of diverse lentivirus types.

Purpose of the Study:

  • To review the properties of lentiviral vectors derived from simian immunodeficiency virus (SIV).
  • To comparatively examine transduction efficiency and biosafety of different lentiviral vectors.
  • To address the need for diverse lentiviral vector designs for clinical applications.

Main Methods:

  • Review of existing literature on lentiviral vectors.

Related Experiment Videos

  • Comparative analysis of transduction efficiency and biosafety data.
  • Focus on vectors derived from simian immunodeficiency virus (SIV).

    • Main Results:

    • Lentiviral vectors enable stable transgene integration into quiescent cells, a key advantage over traditional retroviral vectors.
    • Vectors derived from various lentiviruses, including SIV, show potential for in vivo gene delivery.
    • Ongoing safety evaluations are crucial for clinical acceptance of lentiviral vectors.

    Conclusions:

    • Simian immunodeficiency virus (SIV)-derived lentiviral vectors warrant further investigation for gene therapy applications.
    • A broader range of lentiviral vectors needs to be explored to balance efficacy and safety.
    • Continued research into lentiviral vector biosafety is essential for advancing gene therapy.